Outcomes Following Cyst Curettage and Bone Grafting for the Management of Periprosthetic Cystic Evolution After AES Total Ankle Replacement - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Clinics in Podiatric Medicine and Surgery Année : 2013

Outcomes Following Cyst Curettage and Bone Grafting for the Management of Periprosthetic Cystic Evolution After AES Total Ankle Replacement

Résumé

Bone cysts associated with total ankle replacement: Since 2008, severe medium-term cystic bone evolution was reported with AES total ankle replacement, inducing risk of mechanical complications. Curettage-grafting in periprosthetic cyst: The objective of the present study was to determine whether this technique provided a therapeutic solution, avoiding implant removal and arthrodesis. Results of the various grafts used: Iliac crest autograft, calcium phosphate cement, and polymethylmethacrylate cement were used. With a 79% functional and 92% radiological failure rate, our results in periprosthetic cyst grafting are poor. The principal surgical objective, of avoiding conversion to arthrodesis, failed in 28% of cases. Our present recommendations in evolutive periprosthetic cyst after total ankle replacement: We recommend annual radiological surveillance, with computed tomography (CT) in the case of increased cyst size and/or pain, so as to be able to suggest implant removal and reconstruction-arthrodesis before the talar component collapses. Onset of pain is generally related to microfracture induced by cortical lysis, detectable on CT ahead of implant migration.
Fichier non déposé

Dates et versions

hal-00919780 , version 1 (17-12-2013)

Identifiants

Citer

Jean-Luc Besse, C Lienhard, Michel-Henri Fessy. Outcomes Following Cyst Curettage and Bone Grafting for the Management of Periprosthetic Cystic Evolution After AES Total Ankle Replacement. Clinics in Podiatric Medicine and Surgery, 2013, 30 (2), pp. 157-170. ⟨10.1016/j.cpm.2012.10.005⟩. ⟨hal-00919780⟩
41 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More